메뉴 건너뛰기




Volumn 30, Issue 7, 2015, Pages 1573-1579

Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: A randomized controlled trial

Author keywords

acquired immunodeficiency syndrome; intrauterine contraceptive device; IUC removal; laboratory screening; sexually transmitted infections

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE REMOVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE DEVICE EXPULSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MORBIDITY; OUTCOME ASSESSMENT; PELVIC EXAMINATION; PELVIC INFLAMMATORY DISEASE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; VAGINA DISCHARGE; ADVERSE EFFECTS; HIV INFECTIONS; SEXUALLY TRANSMITTED DISEASES; SINGLE BLIND PROCEDURE; STATISTICS AND NUMERICAL DATA; UGANDA; YOUNG ADULT;

EID: 84936752300     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev109     Document Type: Article
Times cited : (3)

References (32)
  • 2
    • 84896543930 scopus 로고    scopus 로고
    • Worldwide use of intrauterine contraception: A review
    • Buhling KJ, Zite NB, Lotke P, Black K. Worldwide use of intrauterine contraception: a review. Contraception 2014;89:162-173.
    • (2014) Contraception , vol.89 , pp. 162-173
    • Buhling, K.J.1    Zite, N.B.2    Lotke, P.3    Black, K.4
  • 5
    • 0026520859 scopus 로고
    • Intrauterine devices and pelvic inflammatory disease: An international perspective
    • Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339:785-788.
    • (1992) Lancet , vol.339 , pp. 785-788
    • Farley, T.M.1    Rosenberg, M.J.2    Rowe, P.J.3    Chen, J.H.4    Meirik, O.5
  • 7
    • 0034675262 scopus 로고    scopus 로고
    • Intrauterine device and upper-genital-tract infection
    • Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013-1019.
    • (2000) Lancet , vol.356 , pp. 1013-1019
    • Grimes, D.A.1
  • 8
    • 0035235287 scopus 로고    scopus 로고
    • Antibiotic prophylaxis for intrauterine contraceptive device insertion
    • Grimes DA, Lopez LM, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 1999. doi:10. 1002/14651858. CD001327.
    • (1999) Cochrane Database Syst Rev
    • Grimes, D.A.1    Lopez, L.M.2    Schulz, K.F.3
  • 10
    • 33750012689 scopus 로고    scopus 로고
    • The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women-effects on bleeding patterns, ovarian function and genital shedding of HIV
    • Heikinheimo O, Lehtovirta P, Suni J, Paavonen J. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women-effects on bleeding patterns, ovarian function and genital shedding of HIV. Hum Reprod 2006;21:2857-2861.
    • (2006) Hum Reprod , vol.21 , pp. 2857-2861
    • Heikinheimo, O.1    Lehtovirta, P.2    Suni, J.3    Paavonen, J.4
  • 11
    • 0014626656 scopus 로고
    • Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy
    • Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol 1969;105:1088-1098.
    • (1969) Am J Obstet Gynecol , vol.105 , pp. 1088-1098
    • Jacobson, L.1    Westrom, L.2
  • 16
    • 30644456797 scopus 로고    scopus 로고
    • Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection A systematic review
    • Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection A systematic review. Contraception 2006;73:145-153.
    • (2006) Contraception , vol.73 , pp. 145-153
    • Mohllajee, A.P.1    Curtis, K.M.2    Peterson, H.B.3
  • 19
    • 77950189829 scopus 로고    scopus 로고
    • CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
    • Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Br Med J 2010; 340:c332.
    • (2010) Br Med J , vol.340 , pp. c332
    • Schulz, K.F.1    Altman, D.G.2    Moher, D.3
  • 20
    • 27144511739 scopus 로고    scopus 로고
    • A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: Breast-feeding performance, infant growth and infant development
    • Shaamash AH, Sayed GH, Hussien MM, Shaaban MM. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Contraception 2005; 72:346-351.
    • (2005) Contraception , vol.72 , pp. 346-351
    • Shaamash, A.H.1    Sayed, G.H.2    Hussien, M.M.3    Shaaban, M.M.4
  • 21
    • 0035835432 scopus 로고    scopus 로고
    • Risk of clinical pelvic inflammatory disease attributable to an intrauterine device
    • Shelton JD. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet 2001;357:443.
    • (2001) Lancet , vol.357 , pp. 443
    • Shelton, J.D.1
  • 23
    • 0032565332 scopus 로고    scopus 로고
    • Complications of use of intrauterine devices among HIV-1-infected women
    • Sinei SK, Morrison CS, Sekadde-Kigondu C, Allen M, Kokonya D. Complications of use of intrauterine devices among HIV-1-infected women. Lancet 1998;351:1238-1241.
    • (1998) Lancet , vol.351 , pp. 1238-1241
    • Sinei, S.K.1    Morrison, C.S.2    Sekadde-Kigondu, C.3    Allen, M.4    Kokonya, D.5
  • 24
    • 2442464794 scopus 로고    scopus 로고
    • Intrauterine contraceptive devices and risk of pelvic inflammatory disease: Standard of care in high STI prevalence settings
    • Steen R, Shapiro K. Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings. Reprod Health Matters 2004;12:136-143.
    • (2004) Reprod Health Matters , vol.12 , pp. 136-143
    • Steen, R.1    Shapiro, K.2
  • 25
    • 3342894947 scopus 로고    scopus 로고
    • Contraceptive failure in the United States
    • Trussell J. Contraceptive failure in the United States. Contraception 2004; 70:89-96.
    • (2004) Contraception , vol.70 , pp. 89-96
    • Trussell, J.1
  • 27
    • 84876386689 scopus 로고    scopus 로고
    • Drug interactions between antiretrovirals and hormonal contraceptives
    • Tseng A, Hills-Nieminen C. Drug interactions between antiretrovirals and hormonal contraceptives. Expert Opin Drug Metab Toxicol 2013; 9:559-572.
    • (2013) Expert Opin Drug Metab Toxicol , vol.9 , pp. 559-572
    • Tseng, A.1    Hills-Nieminen, C.2
  • 28
    • 84878880014 scopus 로고    scopus 로고
    • Uganda Bureau of Statistics (UBOS) and ICF International Inc. Kampala, Uganda: UBOS and Claverton, Maryland: ICF International Inc. (24 November 2014, date last accessed)
    • Uganda Bureau of Statistics (UBOS) and ICF International Inc. 2012. Uganda Demographic and Health Survey 2011. Kampala, Uganda: UBOS and Claverton, Maryland: ICF International Inc. http://www. ubos. org/ onlinefiles/uploads/ubos/UDHS/UDHS2011. pdf (24 November 2014, date last accessed).
    • (2012) Uganda Demographic and Health Survey 2011
  • 29
    • 85026876768 scopus 로고    scopus 로고
    • United Nations, (24 November 2014, date last accessed)
    • United Nations, 2013. Trends in Contraceptive Methods UsedWorldwide http://www. un. org/en/development/desa/population/publications/ pdf/popfacts/PopFacts-2013-9-new. pdf (24 November 2014, date last accessed).
    • (2013) Trends in Contraceptive Methods UsedWorldwide
  • 30
    • 79957661127 scopus 로고    scopus 로고
    • African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial
    • Venkatesh KK, van der Straten A, Mayer KH, Blanchard K, Ramjee G, Lurie MN, Chipato T, Padian NS, de Bruyn G. African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis 2011;38:562-570.
    • (2011) Sex Transm Dis , vol.38 , pp. 562-570
    • Venkatesh, K.K.1    Van Der Straten, A.2    Mayer, K.H.3    Blanchard, K.4    Ramjee, G.5    Lurie, M.N.6    Chipato, T.7    Padian, N.S.8    De Bruyn, G.9
  • 32
    • 77956604422 scopus 로고    scopus 로고
    • World Health Organisation, Geneva: World Health Organization, (24 November 2014, date last accessed), 4th edn
    • World Health Organisation. Medical Eligibility Criteria for Contraceptive Use, 4th edn. Geneva: World Health Organization, 2009. http://whqlibdoc. who. int/publications/2010/9789241563888-eng. pdf (24 November 2014, date last accessed).
    • (2009) Medical Eligibility Criteria for Contraceptive Use


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.